Institutional investors purchased a net $781.9 thousand shares of NLNK during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 52.62% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 97.0 Thousand shares of NewLink Genetics Corp
HANDELSBANKEN FONDER AB Bought 11.4 Thousand shares of NewLink Genetics Corp